ZA975828B - Stable medicament for oral administration and method for its production. - Google Patents
Stable medicament for oral administration and method for its production.Info
- Publication number
- ZA975828B ZA975828B ZA9705828A ZA975828A ZA975828B ZA 975828 B ZA975828 B ZA 975828B ZA 9705828 A ZA9705828 A ZA 9705828A ZA 975828 A ZA975828 A ZA 975828A ZA 975828 B ZA975828 B ZA 975828B
- Authority
- ZA
- South Africa
- Prior art keywords
- oral administration
- production
- resistant
- core
- gastric juice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19626045A DE19626045C2 (de) | 1996-06-28 | 1996-06-28 | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA975828B true ZA975828B (en) | 1998-01-30 |
Family
ID=7798347
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9705827A ZA975827B (en) | 1996-06-28 | 1997-06-30 | Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production. |
ZA9705828A ZA975828B (en) | 1996-06-28 | 1997-06-30 | Stable medicament for oral administration and method for its production. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9705827A ZA975827B (en) | 1996-06-28 | 1997-06-30 | Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0934058B1 (xx) |
JP (1) | JP4641075B2 (xx) |
AT (1) | ATE247457T1 (xx) |
AU (2) | AU3438897A (xx) |
CA (1) | CA2258918C (xx) |
DE (2) | DE19626045C2 (xx) |
DK (1) | DK0934058T3 (xx) |
ES (1) | ES2205243T3 (xx) |
PT (1) | PT934058E (xx) |
WO (2) | WO1998000114A2 (xx) |
ZA (2) | ZA975827B (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
ATE321538T1 (de) | 1998-08-12 | 2006-04-15 | Altana Pharma Ag | Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
IL130602A0 (en) | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
US6420473B1 (en) * | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
US7316819B2 (en) * | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
KR100479637B1 (ko) * | 2002-02-01 | 2005-03-31 | 한국화학연구원 | 란소프라졸을 함유하는 경구제제 및 그의 제조방법 |
PT1524967E (pt) | 2002-08-02 | 2008-04-03 | Ratiopharm Gmbh | Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação. |
DE10235475B4 (de) * | 2002-08-02 | 2006-04-27 | Ratiopharm Gmbh | Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
AR045068A1 (es) * | 2003-07-23 | 2005-10-12 | Univ Missouri | Formulacion de liberacion inmediata de composiciones farmaceuticas |
CN100508976C (zh) * | 2003-07-24 | 2009-07-08 | 史密丝克莱恩比彻姆公司 | 口腔溶解薄膜 |
WO2005084649A1 (ja) * | 2004-03-04 | 2005-09-15 | Takeda Pharmaceutical Company Limited | 安定なカプセル剤 |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20090208575A1 (en) * | 2005-01-03 | 2009-08-20 | Lupin Limited | Pharmaceutical Composition Of Acid Labile Substances |
DE102005032806A1 (de) * | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
DE102006006532B4 (de) | 2006-02-10 | 2007-11-08 | Biogenerics Pharma Gmbh | Pharmazeutische Zubereitung |
SI2152250T1 (sl) * | 2007-05-07 | 2020-06-30 | Evonik Operations Gmbh | Trdne dozirne oblike, ki vsebujejo enterično oplaščenje s pospešenim sproščanjem zdravila |
DE102008056312A1 (de) | 2008-11-07 | 2010-05-12 | Biogenerics Pharma Gmbh | Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz |
DE102010052847A1 (de) * | 2010-11-29 | 2012-05-31 | Temmler Werke Gmbh | Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung |
US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
JP5934835B2 (ja) * | 2013-03-08 | 2016-06-15 | 富士フイルム株式会社 | 腸溶性細粒及び医薬組成物 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CN111954521B (zh) * | 2018-04-12 | 2023-02-17 | Bpsi控股有限责任公司 | 酸化包衣和由其包衣的抗崩解基质 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57171428A (en) * | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
JPS584730A (ja) * | 1981-06-29 | 1983-01-11 | Shin Etsu Chem Co Ltd | 腸溶性コ−テイング組成物およびその製造方法 |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DE3822095A1 (de) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | Neue arzneimittelformulierung sowie verfahren zu deren herstellung |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
US5225202A (en) * | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
JPH0733659A (ja) * | 1992-07-17 | 1995-02-03 | Yoshitomi Pharmaceut Ind Ltd | 抗潰瘍剤含有製剤 |
AU4513393A (en) * | 1992-07-17 | 1994-02-14 | Astra Aktiebolag | Pharmaceutical composition containing antiulcer agent |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
-
1996
- 1996-06-28 DE DE19626045A patent/DE19626045C2/de not_active Expired - Fee Related
-
1997
- 1997-06-27 WO PCT/EP1997/003387 patent/WO1998000114A2/de active IP Right Grant
- 1997-06-27 DE DE59710629T patent/DE59710629D1/de not_active Expired - Lifetime
- 1997-06-27 AU AU34388/97A patent/AU3438897A/en not_active Abandoned
- 1997-06-27 EP EP97929304A patent/EP0934058B1/de not_active Expired - Lifetime
- 1997-06-27 CA CA002258918A patent/CA2258918C/en not_active Expired - Fee Related
- 1997-06-27 JP JP50383698A patent/JP4641075B2/ja not_active Expired - Fee Related
- 1997-06-27 AT AT97929304T patent/ATE247457T1/de active
- 1997-06-27 DK DK97929304T patent/DK0934058T3/da active
- 1997-06-27 WO PCT/EP1997/003388 patent/WO1998000115A2/de active Application Filing
- 1997-06-27 ES ES97929304T patent/ES2205243T3/es not_active Expired - Lifetime
- 1997-06-27 PT PT97929304T patent/PT934058E/pt unknown
- 1997-06-27 AU AU33451/97A patent/AU3345197A/en not_active Abandoned
- 1997-06-30 ZA ZA9705827A patent/ZA975827B/xx unknown
- 1997-06-30 ZA ZA9705828A patent/ZA975828B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PT934058E (pt) | 2004-01-30 |
CA2258918C (en) | 2005-11-22 |
DE19626045C2 (de) | 1998-12-03 |
DK0934058T3 (da) | 2003-12-01 |
JP2000514051A (ja) | 2000-10-24 |
JP4641075B2 (ja) | 2011-03-02 |
EP0934058A2 (de) | 1999-08-11 |
DE19626045A1 (de) | 1998-01-08 |
AU3438897A (en) | 1998-01-21 |
WO1998000114A2 (de) | 1998-01-08 |
WO1998000115A3 (de) | 1998-02-26 |
EP0934058B1 (de) | 2003-08-20 |
DE59710629D1 (de) | 2003-09-25 |
CA2258918A1 (en) | 1998-01-08 |
WO1998000114A3 (de) | 1998-02-26 |
AU3345197A (en) | 1998-01-21 |
ZA975827B (en) | 1998-01-30 |
ES2205243T3 (es) | 2004-05-01 |
WO1998000115A2 (de) | 1998-01-08 |
ATE247457T1 (de) | 2003-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA975828B (en) | Stable medicament for oral administration and method for its production. | |
GEP20033014B (en) | Enteric Coated Pharmaceutical Composition and Method of Manufacturing | |
AU531280B2 (en) | Cardiac glycoside composition | |
MY102675A (en) | Pharmaceutical formulations of acid labile substances for oral use. | |
ES2006649A6 (es) | Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma. | |
CA2232356A1 (en) | Method of producing multi-layer medicaments in solid form for oral or rectal administration | |
HU908404D0 (en) | Process for the production of preparations with 1-carnitine content | |
IE881916L (en) | Press-coated dihydropyridine tablets | |
IT1245761B (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. | |
EP0348808A3 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung | |
EP0729748A4 (en) | METHOD FOR PRODUCING STABLE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATION | |
NZ322053A (en) | Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers | |
CA2219991A1 (en) | Taste masking pharmaceutical composition for oral administration | |
WO2002005829A3 (en) | Methods and formultations with probiotic microorganisms and medicaments | |
MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
CA2282082A1 (fr) | Microgranules contenant du cisplatine | |
WO1999007401A3 (de) | Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen | |
NO992944L (no) | Virkestoffbµrer for avgivelse av apomorfin i munnhulen | |
AU1935788A (en) | A process for producing an administration and/or dosage form for medically active ingredients of drugs | |
AU6788687A (en) | A pharmaceutical which can be administered nasally, a process for its preparation, and its use | |
GR3034646T3 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them | |
NO326141B1 (no) | Fremgangsmate for behandling av isolert systolisk hypertensjon | |
HUT56487A (en) | Process for producing solid pharmaceutical composition decomposing in stomach | |
GR1003199B (el) | Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες | |
DE69306118D1 (de) | Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel |